Fiorucci Stefano,Pelliciari Roberto,Pruzanski Mark
申请号：
SI200532120
公开号：
SI2712617T1
申请日:
2005.03.14
申请国别(地区):
SI
年份:
2017
代理人:
摘要：
The present invention relates to a method for inhibiting fibrosis that occurs in an organ where the farnesoid X receptor (FXR) is expressed. This method involves the step of administering a high potency, activating ligand of FXR in an effective amount to a patient who is not suffering from a cholestatic condition. The invention also provides pharmaceutical compositions containing an effective amount of an FXR ligand and kits for dispensing the pharmaceutical compositions.
